Orgovyx (relugolix) is a prescription medication used to treat advanced prostate cancer in adults. It works by suppressing testosterone, the hormone that fuels prostate cancer growth, and it’s the first oral medication in its class, replacing what has traditionally required injections or implants.
How Orgovyx Treats Prostate Cancer
Prostate cancer cells rely on testosterone to grow and spread. The standard approach to advanced prostate cancer for decades has been to cut off that testosterone supply, a strategy called androgen deprivation therapy (ADT). Before Orgovyx, this meant regular injections or implants every one to six months at a doctor’s office.
Orgovyx takes a different route. It blocks a signaling receptor in the brain’s pituitary gland, which is the control center for hormone production. By blocking this receptor, the drug shuts down the release of two key signaling hormones that tell the body to produce testosterone. The result is a rapid, deep drop in testosterone levels to what’s considered “castrate” range, below 50 ng/dL, which starves the cancer of its primary fuel.
How Well It Works
In the HERO trial, the largest study of its kind, Orgovyx outperformed the standard injectable treatment (leuprolide). Among men taking Orgovyx, 97% achieved sustained testosterone suppression to castrate levels over 48 weeks, compared to 89% of men on the injectable. That 8-percentage-point gap was statistically significant.
One practical advantage is speed. Injectable ADT drugs cause an initial spike in testosterone before suppressing it, a phenomenon called a “flare” that can temporarily worsen symptoms. Orgovyx doesn’t trigger this flare because it blocks the hormone signal directly rather than overstimulating it first. Testosterone levels begin dropping within days of starting the medication.
How It’s Taken
Orgovyx is a daily pill, which is a significant shift from the injection-based options most men with advanced prostate cancer have used. The schedule works like this:
- Day one: A loading dose of three tablets (360 mg total)
- Every day after: One tablet (120 mg), taken at roughly the same time each day
Consistency matters with this medication. If you miss doses for more than seven days in a row, you need to restart with the three-tablet loading dose again before going back to the daily single tablet. This restart protocol exists because testosterone levels can begin rising once the drug clears your system, so gaps in treatment can undermine its effectiveness.
Testosterone Recovery After Stopping
One of the reasons some oncologists favor Orgovyx over injectable options is what happens when treatment ends. Because it’s a daily pill that clears the body relatively quickly, testosterone levels tend to start recovering sooner after discontinuation compared to long-acting injections that linger in the body for weeks or months.
That said, testosterone recovery after any form of ADT is not guaranteed. Research from Memorial Sloan Kettering found that roughly one in four men failed to return their testosterone to normal levels (above 300 ng/dL) within two years of stopping ADT, and about one in ten remained at castrate levels. The odds of delayed recovery were nearly four times higher in men who received ADT for longer than six months and more than three times higher in those whose testosterone was already on the lower end before treatment began. So while Orgovyx offers a faster off-switch than injections, full hormonal recovery remains uncertain for a meaningful number of men, particularly after prolonged use.
Side Effects
Most of the side effects associated with Orgovyx are the same ones tied to testosterone suppression itself, not unique to the drug. When you dramatically lower testosterone, the body responds in predictable ways. The most commonly reported effects include hot flashes, fatigue, joint and muscle pain, decreased sex drive, and constipation or diarrhea. Weight gain and increased blood sugar are also possible over time, as testosterone plays a role in metabolism and body composition.
One area where Orgovyx appears to have an edge is cardiovascular safety. In the HERO trial, men taking Orgovyx had roughly half the rate of major cardiovascular events compared to those on the injectable option. This is particularly relevant because many men with advanced prostate cancer are older and already have heart disease risk factors. The lower cardiovascular signal with Orgovyx has made it an especially appealing choice for men with a history of heart problems.
Drug Interactions to Know About
Orgovyx is processed in the body through a transport system called P-glycoprotein (P-gp). Certain medications can interfere with this system, either increasing or decreasing how much Orgovyx your body absorbs. Drugs that inhibit P-gp can raise Orgovyx levels in your bloodstream, while drugs that induce P-gp can lower them, potentially making the medication less effective. Common P-gp interactors include some heart medications, antifungals, seizure drugs, and certain antibiotics. Your prescribing team will review your full medication list before starting treatment.
Who Orgovyx Is For
Orgovyx is FDA-approved specifically for adult patients with advanced prostate cancer. “Advanced” in this context generally means cancer that has spread beyond the prostate or that has recurred after initial treatment. It’s used both as a standalone therapy and alongside other prostate cancer treatments, depending on the stage and aggressiveness of the disease.
For men who travel frequently, have difficulty getting to regular injection appointments, or simply prefer managing their treatment at home, the oral format can be a meaningful quality-of-life improvement. The tradeoff is that it requires daily discipline: missing doses directly affects how well the drug controls testosterone, and there’s no long-acting depot in the body to provide a buffer the way an injection does.